The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Book Review
PreviousPrevious
Volume 339:1009 October 1, 1998 Number 14

Ovarian Cancer: Controversies in management

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
Edited by David M. Gershenson and William P. McGuire. 463 pp. New York, Churchill Livingstone, 1998. $75. ISBN 0-443-07804-1.

Of all the malignant conditions of the female genital system, ovarian cancer causes the most deaths. Unfortunately, little progress has been made in the fight against this cancer, although in the past few years the use of refined and more radical surgical techniques and adjuvant combination therapy have significantly improved survival. Response to initial therapy is the rule, but in the majority of patients progressive or recurrent disease develops after a rather short disease-free interval, usually one of only a few months.

There is a need for a book that furnishes physicians and scientists with new opportunities and refined strategies . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.